| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Gordon Guyatt | Q5585214 |
| Bradley C Johnston | Q123434367 | ||
| Kristian Thorlund | Q30089886 | ||
| Per Olav Vandvik | Q57313206 | ||
| P2093 | author name string | Mark R Martzen | |
| Joshua Z Goldenberg | |||
| Jane D Saxton | |||
| Stephanie SY Ma | |||
| P2860 | cites work | Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients | Q21195017 |
| Probiotics for the prevention of pediatric antibiotic-associated diarrhea | Q24235039 | ||
| Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis | Q24529831 | ||
| Systematic review and meta-analysis of Saccharomyces boulardii in adult patients | Q24621081 | ||
| Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial | Q24628564 | ||
| Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study | Q24653790 | ||
| Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial | Q24655137 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| The PAV trial: does lactobacillus prevent post-antibiotic vulvovaginal candidiasis? Protocol of a randomised controlled trial [ISRCTN24141277] | Q24797617 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| GRADE: an emerging consensus on rating quality of evidence and strength of recommendations | Q27860753 | ||
| Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial | Q28142345 | ||
| How should meta-regression analyses be undertaken and interpreted? | Q28193388 | ||
| Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial | Q28237525 | ||
| Randomised clinical trial: the synbiotic food supplement Probiotical vs. placebo for acute gastroenteritis in children | Q28247362 | ||
| Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study | Q69182379 | ||
| The effect of probiotics on Clostridium difficile diarrhea | Q73351179 | ||
| Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota | Q79399869 | ||
| Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics | Q79806151 | ||
| Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink | Q79933005 | ||
| Benefits of oral supplementation with and without synbiotics in young children with acute bacterial infections | Q79955318 | ||
| Lactobacillus plantarum 299v enhances the concentrations of fecal short-chain fatty acids in patients with recurrent clostridium difficile-associated diarrhea | Q80127484 | ||
| Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy | Q80180228 | ||
| Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children | Q80272591 | ||
| A probiotic drink prevented diarrhoea and Clostridium difficile-associated diarrhoea in older patients taking antibiotics | Q80949535 | ||
| Probiotics for recurrent Clostridium difficile disease | Q81038028 | ||
| Efficacy of Clostridium butyricum preparation concomitantly with Helicobacter pylori eradication therapy in relation to changes in the intestinal microbiota | Q81055766 | ||
| Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children | Q81078669 | ||
| Efficacy of Lactobacillus rhamnosus GG in acute watery diarrhoea of Indian children: a randomised controlled trial | Q81095722 | ||
| The effect of fermented yogurt on the prevention of diarrhea in a healthy adult population | Q81509642 | ||
| Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients | Q82849324 | ||
| Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori | Q83038427 | ||
| The effect of Lactobacillus casei and Bifidobacterium breve on antibiotic-associated diarrhea treatment: randomized double-blind clinical trial | Q83524451 | ||
| A randomized clinical trial measuring the influence of kefir on antibiotic-associated diarrhea: the measuring the influence of Kefir (MILK) Study | Q84342755 | ||
| Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity | Q84837086 | ||
| A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease | Q28254686 | ||
| Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis | Q28266275 | ||
| Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study | Q28271581 | ||
| Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial | Q29394639 | ||
| Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature | Q29614233 | ||
| A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints | Q29614902 | ||
| Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials | Q29620299 | ||
| Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers | Q30596302 | ||
| Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. | Q32010564 | ||
| Identification and impact of outcome selection bias in meta-analysis | Q33209578 | ||
| Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study | Q33426019 | ||
| Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea | Q33451610 | ||
| Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study | Q33878836 | ||
| Intestinal lactoflora in Estonian and Norwegian patients with antibiotic associated diarrhea | Q33891757 | ||
| Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial | Q33995797 | ||
| A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children | Q34013199 | ||
| Does taking probiotics routinely with antibiotics prevent antibiotic associated diarrhoea? | Q34030781 | ||
| A multicentre randomised controlled trial evaluating lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea in older people admitted to hospital: the PLACIDE study protocol. | Q34257705 | ||
| Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis | Q34325227 | ||
| Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial. | Q34572969 | ||
| Probiotics in human infections | Q34983703 | ||
| Effect of a lactobacillus preparation on the absorption of oral ampicillin | Q35647834 | ||
| Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli | Q35670969 | ||
| A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome | Q35840560 | ||
| Does eating yogurt prevent antibiotic-associated diarrhoea? A placebo-controlled randomised controlled trial in general practice | Q36156241 | ||
| Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review | Q36199514 | ||
| Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy | Q36497178 | ||
| Why sources of heterogeneity in meta-analysis should be investigated | Q36888653 | ||
| Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials | Q37678738 | ||
| Economic healthcare costs of Clostridium difficile infection: a systematic review | Q37691876 | ||
| Health benefits of probiotics: are mixtures more effective than single strains? | Q37828084 | ||
| Treating bugs with bugs: the role of probiotics as adjunctive therapy for Helicobacter pylori. | Q37892763 | ||
| <i>Escherichia coli</i> Nissle 1917 (Mutaflor): New Insights into an Old Probiotic Bacterium | Q37969596 | ||
| Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review | Q38011678 | ||
| ??? | Q59408529 | ||
| Graphical augmentations to the funnel plot assess the impact of additional evidence on a meta-analysis | Q39651453 | ||
| Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial | Q40651311 | ||
| Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials | Q42470900 | ||
| The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin | Q43352809 | ||
| Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery | Q43354248 | ||
| Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients | Q43354697 | ||
| Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients | Q43678916 | ||
| Effect of lactic acid producing bacteria on the human intestinal microflora during ampicillin treatment | Q44014276 | ||
| Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial | Q44147671 | ||
| Effect of Lactobacillus F19 on the emergence of antibiotic-resistant microorganisms in the intestinal microflora | Q45030422 | ||
| The probiotic effect of Saccharomyces boulardii in a pediatric age group | Q45051635 | ||
| Impact of mandatory Clostridium difficile surveillance on diagnostic services | Q45141273 | ||
| Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis | Q45166043 | ||
| Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial | Q45166053 | ||
| A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea | Q45204724 | ||
| Feasibility and tolerability of probiotics for prevention of antibiotic-associated diarrhoea in hospitalized US military veterans | Q45331637 | ||
| Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses | Q45356123 | ||
| Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial | Q46084042 | ||
| Effect of probiotic Saccharomyces boulardii on prevention of antibiotic-associated diarrhea in adult outpatients with amoxicillin treatment | Q46299377 | ||
| Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics | Q46327781 | ||
| Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. | Q46541149 | ||
| Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication | Q46807963 | ||
| Effect of a milk formula with prebiotics on the intestinal microbiota of infants after an antibiotic treatment | Q46956158 | ||
| Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates | Q47172563 | ||
| Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial | Q47440727 | ||
| Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study. | Q47799889 | ||
| The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients | Q50891759 | ||
| Probiotics for prevention of antibiotic‐associated diarrhea and Clostridium difficile‐associated disease in hospitalized adults—A meta‐analysis | Q51028708 | ||
| A Randomized, Double-blind, Placebo-controlled Pilot Study of Lactobacillus reuteri ATCC 55730 for the Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults | Q51466665 | ||
| Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study | Q51743963 | ||
| Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics | Q51812061 | ||
| Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double-blind, placebo-controlled pilot study | Q52563743 | ||
| Publication bias and dissemination of clinical research | Q52867734 | ||
| Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery - results of a prospective trial | Q52954423 | ||
| Effects of multistrain probiotic‐containing yogurt on second‐line triple therapy for Helicobacter pylori infection | Q53446207 | ||
| Oral supplementation with lactic acid-producing bacteria during intake of clindamycin. | Q54570942 | ||
| Evaluation of five probiotic products for label claims by DNA extraction and polymerase chain reaction analysis. | Q54656417 | ||
| A Randomized Formula Controlled Trial of Bifidobacterium lactis and Streptococcus thermophilus for Prevention of Antibiotic-Associated Diarrhea in Infants | Q58227623 | ||
| The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy | Q58228933 | ||
| Conducting Meta-Analyses in R with the metafor Package | Q58423162 | ||
| Spontaneously fermented millet product as a natural probiotic treatment for diarrhoea in young children: An intervention study in Northern Ghana | Q58816519 | ||
| P921 | main subject | diarrhea | Q40878 |
| Clostridium difficile | Q310543 | ||
| prevention | Q1717246 | ||
| probiotics | Q1816730 | ||
| P577 | publication date | 2013-05-31 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children |
| Q63230054 | 2019 update of the WSES guidelines for management of () infection in surgical patients |
| Q64058715 | A Review of Mixed Strain Colonization and Infection |
| Q38924955 | A few of our favorite unconfirmed ideas |
| Q58798841 | A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The Netherlands |
| Q41992918 | A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO). |
| Q35164905 | A review of the economics of treating Clostridium difficile infection |
| Q38427654 | A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union |
| Q36018083 | Administration of probiotic kefir to mice with Clostridium difficile infection exacerbates disease |
| Q28066362 | Advances in the Microbiome: Applications to Clostridium difficile Infection |
| Q29365161 | Alternatives to antibiotics—a pipeline portfolio review |
| Q64080527 | An Updated Review of Clostridium difficile Treatment in Pediatrics |
| Q61449726 | Antiamoebic drugs for treating amoebic colitis |
| Q33834926 | Assessing control bundles for Clostridium difficile: a review and mathematical model |
| Q35918566 | Breakthroughs in the treatment and prevention of Clostridium difficile infection |
| Q35832867 | Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children |
| Q38225464 | Bugs or drugs: are probiotics safe for use in the critically ill? |
| Q41545688 | Clinical Characteristics of Symptomatic Clostridium difficile Infection in Children: Conditions as Infection Risks and Whether Probiotics Is Effective |
| Q56225357 | Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) |
| Q57043479 | Clostridioides difficile Infection |
| Q38445227 | Clostridium Difficile Infection from a Surgical Perspective. |
| Q36310096 | Clostridium Difficile Infection in Acute Care Hospitals: Systematic Review and Best Practices for Prevention |
| Q60500782 | Clostridium difficile infection |
| Q37572834 | Clostridium difficile infection in cystic fibrosis: an uncommon but life-threatening complication |
| Q37289567 | Clostridium difficile infection in the twenty-first century |
| Q37563993 | Clostridium difficile infection: a worldwide disease |
| Q26864237 | Clostridium difficile infection: molecular pathogenesis and novel therapeutics |
| Q41990887 | Clostridium difficile infection: new approaches to prevention, non-antimicrobial treatment, and stewardship |
| Q92835483 | Clostridium difficile infection: review |
| Q38538221 | Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection |
| Q47136286 | Cost-Effectiveness Analysis of Probiotic Use to Prevent Clostridium difficile Infection in Hospitalized Adults Receiving Antibiotics |
| Q41960230 | Cost-benefit relation of diet and probiotics in iatrogenic bowel irregularity (IBI). |
| Q38334278 | Diagnosis and treatment of Clostridium difficile in adults: a systematic review. |
| Q44763738 | Editorial Commentary: looking to the future: vertical vs horizontal prevention of Clostridium difficile infections |
| Q35848822 | Effectiveness of probiotic in preventing and treating antibiotic-associated diarrhoea and/or Clostridium difficile-associated diarrhoea in patients with spinal cord injury: a protocol of systematic review of randomised controlled trials |
| Q89731185 | Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer's disease or mild cognitive impairment - a meta-analysis of randomized controlled trials |
| Q90093092 | Emerging Priorities for Microbiome Research |
| Q42369781 | Emerging Trends in "Smart Probiotics": Functional Consideration for the Development of Novel Health and Industrial Applications |
| Q38801764 | Eosinophils, probiotics, and the microbiome. |
| Q28241661 | Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic |
| Q54226920 | Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Prevention of Antibiotic Associated Diarrhea and Clostridium difficile |
| Q34827720 | Fecal transplant policy and legislation |
| Q36014797 | Fermented Milk Consumption and Common Infections in Children Attending Day-Care Centers: A Randomized Trial |
| Q35025946 | Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target |
| Q35616074 | Gut microbiome, gut function, and probiotics: Implications for health. |
| Q37718870 | Harnessing microbiome and probiotic research in sub-Saharan Africa: recommendations from an African workshop |
| Q49433372 | Immune-Mediated Mechanisms of Action of Probiotics and Synbiotics in Treating Pediatric Intestinal Diseases |
| Q40777672 | Importance of Molecular Methods to Determine Whether a Probiotic is the Source of Lactobacillus Bacteremia. |
| Q89258831 | Importance of strain subgroup analysis in probiotic meta-analyses |
| Q37478297 | Infection prevention and control of Clostridium difficile: a global review of guidelines, strategies, and recommendations |
| Q88393518 | Infectious Diseases in Older Adults of Long-Term Care Facilities: Update on Approach to Diagnosis and Management |
| Q27001712 | Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis |
| Q26825756 | Is there a role for probiotics in the prevention of preterm birth? |
| Q33863396 | Lactobacilli and bifidobacteria in human breast milk: influence of antibiotherapy and other host and clinical factors |
| Q38778071 | Lactobacillus probiotics in the prevention of diarrhea associated with Clostridium difficile: a systematic review and Bayesian hierarchical meta-analysis |
| Q51084446 | Leaping Forward in the Treatment of Clostridium Difficile Infection: Update in 2015. |
| Q35044588 | Manipulating the gut microbiota to maintain health and treat disease |
| Q43236528 | Microbiome as mediator: Do systemic infections start in the gut? |
| Q26771287 | Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation |
| Q33742439 | Microorganisms with claimed probiotic properties: an overview of recent literature. |
| Q34554827 | Migraine associated with gastrointestinal disorders: review of the literature and clinical implications |
| Q93110475 | Modified Mouse Model of Clostridioides difficile Infection as a Platform for Probiotic Efficacy Studies |
| Q35862915 | Novel approaches to treating Clostridium difficile-associated colitis. |
| Q37588571 | Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea |
| Q59126496 | Oral probiotic combination of Lactobacillus and Bifidobacterium alters the gastrointestinal microbiota during antibiotic treatment for Clostridium difficile infection |
| Q34423174 | Prebiotics in healthy infants and children for prevention of acute infectious diseases: a systematic review and meta-analysis |
| Q40579622 | Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters |
| Q37189190 | Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis |
| Q49183268 | Probiotics Ingestion Does Not Directly Affect Thyroid Hormonal Parameters in Hypothyroid Patients on Levothyroxine Treatment. |
| Q50224112 | Probiotics and gastrointestinal conditions: An overview of evidence from the Cochrane Collaboration. |
| Q36624142 | Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis |
| Q36018176 | Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for? |
| Q94347829 | Probiotics for people with cystic fibrosis |
| Q49494707 | Probiotics for prevention of Clostridium difficile infection. |
| Q36683562 | Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review |
| Q41850934 | Probiotics for the prevention of Clostridium difficile |
| Q46236620 | Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. |
| Q57166449 | Probiotics for the prevention or treatment of chemotherapy- or radiotherapy-related diarrhoea in people with cancer |
| Q24202087 | Probiotics for the prevention or treatment of chemotherapy or radiotherapy related diarrhoea in cancer patients |
| Q41524789 | Probiotics in addition to antibiotics for the treatment of acute tonsillitis: a randomized, placebo-controlled study |
| Q92876444 | Probiotics in the next-generation sequencing era |
| Q39024657 | Probiotics, D-Lactic acidosis, oxidative stress and strain specificity |
| Q28657826 | Probiotics, prebiotics, and the host microbiome: the science of translation |
| Q35540747 | Progress and challenges in developing metabolic footprints from diet in human gut microbial cometabolism |
| Q35044119 | Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review. |
| Q36399668 | Randomized Controlled Trial to Determine the Impact of Probiotic Administration on Colonization With Multidrug-Resistant Organisms in Critically Ill Patients |
| Q26766112 | Recent Advances in the Diagnosis and Treatment of Clostridium Difficile Infection |
| Q52657241 | Recent Progress for the Effective Prevention and Treatment of Recurrent Clostridium difficile Infection |
| Q34411373 | Recommendations for probiotic use in humans-a 2014 update |
| Q89814511 | Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postope |
| Q28083234 | Reported rates of diarrhea following oral penicillin therapy in pediatric clinical trials |
| Q59413926 | Restoring the balance—microbes for the management of Clostridium difficile infection? |
| Q28087466 | Risk and safety of probiotics |
| Q37341078 | Role of the microbiome, probiotics, and 'dysbiosis therapy' in critical illness |
| Q36670919 | Saccharomyces boulardii to Prevent Antibiotic-Associated Diarrhea: A Randomized, Double-Masked, Placebo-Controlled Trial |
| Q41004993 | Should pediatric infectious diseases physicians be proponents of probiotics? |
| Q42654359 | Sleeping with the enemy: Clostridium difficile infection in the intensive care unit |
| Q85920456 | Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update |
| Q88805433 | Susceptibility to antibiotics in isolates of Lactobacillus plantarum RAPD-type Lp299v, harvested from antibiotic treated, critically ill patients after administration of probiotics |
| Q92570756 | Targeting Microbiota: What Do We Know about It at Present? |
| Q36401310 | The Effect of Lactobacillus plantarum 299v on the Incidence of Clostridium difficile Infection in High Risk Patients Treated with Antibiotics. |
| Q34553267 | The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists |
| Q91816299 | The Importance of the Microbiome in Critically Ill Patients: Role of Nutrition |
| Q36394638 | The Role of the Microbiome and the use Of Probiotics in Gastrointestinal Disorders in Adults in the Asia-Pacific Region |
| Q28075770 | The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood |
| Q27014922 | The role of the gut microbiome in the pathogenesis and treatment of obesity |
| Q64108976 | Treating Viral Diarrhea in Children by Probiotic and Zinc Supplements |
| Q34144918 | Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review |
| Q39391152 | Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses. |
| Q53632775 | Yoghurt and probiotic bacteria in dietary guidelines of the member states of the European Union |
| Q89563930 | [Clostridium difficile in the intensive care unit] |
Search more.